XML 81 R47.htm IDEA: XBRL DOCUMENT
v3.22.0.1

Stockholders' Deficit (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2021
Stockholders' Equity Note [Abstract] |
Schedule of change in the number of shares of Class A common stock | The following reflects total stock-based compensation expense recognized under all programs:
|  |  | Year Ended December 31,
|  |  |  |  | 2021 |  | 2020 |  | 2019
Related to SGC stock options |  |  |  |  | $ | 31 |  |  | $ | 8 |  |  | $ | 4 |
Related to SGC RSUs |  |  |  |  | 75 |  |  | 26 |  |  | 19 |
Related to SciPlay RSUs |  |  |  |  | 7 |  |  | 22 |  |  | 9 |
Total(1)(2) |  |  |  |  | $ | 113 |  |  | $ | 56 |  |  | $ | 32 |
(1) The increase in SGC stock-based compensation expense for the year ended December 31, 2021 is related to the acceleration of the expense as a result of attainment of certain targets for grants to consultants who are also on our board coupled with the new equity awards issued at a higher fair value given the increase in our stock price compared to the prior period.
(2) The year ended December 31, 2021 includes $34 million classified as liability awards.
The following table sets forth the change in the number of shares of common stock outstanding during the fiscal years ended December 31, 2021 and 2020:
|  | December 31,
|  | 2021 |  | 2020
Shares outstanding as of beginning of period |  | 95 |  |  | 94 |
Shares issued as part of equity-based compensation plans and the ESPP, net of shares surrendered |  | 2 |  |  | 1 |
Shares outstanding as of end of period |  | 97 |  |  | 95 |
Share-based Payment Arrangement, Option, Activity | A summary of the changes in stock options outstanding under our equity-based compensation plans during 2021 is presented below:
| Number of Options |  | Weighted Average Remaining Contract Term (Years) |  | Weighted Average Exercise Price (per share) |  | Aggregate Intrinsic Value
Options outstanding as of December 31, 2020 | 2.2 |  |  | 6.2 |  | $ | 32.89 |  |  | $ | 20 |
Granted | — |  |  | — |  |  | $ | 74.16 |  |  | $ | — |
Exercised | 0.2 |  |  | — |  |  | $ | 26.26 |  |  | $ | 7 |
Cancelled | — |  |  | — |  |  | $ | 41.13 |  |  | $ | — |
Options outstanding as of December 31, 2021 | 2.0 |  |  | 5.3 |  | $ | 33.59 |  |  | $ | 68 |
Options exercisable as of December 31, 2021 | 1.8 |  |  | 5.1 |  | $ | 34.19 |  |  | $ | 59 |
Options expected to vest as of December 31, 2021 | 0.2 |  |  | 7.3 |  | $ | 28.96 |  |  | $ | 8 |
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions | The weighted-average assumptions used in the model are outlined in the following table:
| 2021 |  | 2020 |  | 2019
Assumptions: |  |  |  |  |
Expected volatility | 74 | % |  | 75 | % |  | 58 | %
Risk-free interest rate | 0.96 | % |  | 0.36 | % |  | 2.46 | %
Dividend yield | — |  |  | — |  |  | — |
Expected life (in years) | 6 |  | 6 |  | 6
RSUs outstanding under equity-based compensation plans | A summary of the changes in RSUs outstanding under our equity-based compensation plans during 2021 is presented below:
| Number of Restricted Stock Units |  | Weighted Average Grant Date Fair Value
Unvested RSUs as of December 31, 2020 | 3.3 |  |  | $ | 19.07 |
Granted | 1.2 |  |  | $ | 55.64 |
Vested | (1.6) |  |  | $ | 24.70 |
Cancelled | (0.2) |  |  | $ | 27.96 |
Unvested RSUs as of December 31, 2021(1) | 2.7 |  |  | $ | 32.03 |
(1) 1 million unvested RSUs are related to discontinued operations for each of the years ended December 31, 2021 and 2020.

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year. + References No definition available. + Details
Name: | us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration